The Israeli pharmaceutical company claims that over the next year it will have a "complete cure for cancer."
The company is “Accelerated Evolutionary Biotechnology” (AEBi), and, based on the statements of its Chairman, Dan Aridor, the approach it works on sounds revolutionary.
“Our cancer cure will be effective from day one, last for several weeks and will not have or will have minimal side effects at a much lower cost than most other treatments on the market,” said Aridor. The jerusalem post, "Our decision will be both general and personal."
In accordance with The jerusalem postThe treatment for cancer AEBi is called MuTaTo, which means “multipurpose toxin”. It attacks cancer cells with several peptides — compounds containing chains of amino acids — and this multi-pronged attack is the key to the effectiveness of treatment, the Company says.
“We made sure that the treatment was not affected by mutations; cancer cells can mutate in such a way that target receptors fall from cancer, ”said AEBi CEO Ilan Morad. Message, “The likelihood of having multiple mutations that could modify all target receptors simultaneously decreases dramatically with an increase in the number of targets used.”
“Instead of attacking the receptors one at a time, we attack the receptors three at a time,” he continued. "Even cancer cannot mutate three receptors at the same time."
Morad claims in Message that AEBi uses cancer treatment to suppress the growth of cancer cells in mice, without affecting healthy animal cells at all. According to Morad, the company also completed several in vitro tests and will soon begin clinical trials. According to the CEO of AEBi, this may end in a few years, after which treatment may be available in special cases.
This is a lot of claims, but Message The article does not mention the existence of any peer-reviewed research that could support them.